Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Rank in Stocks #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Share Price
$29.82
Last synced: 2023-04-11
Market Cap
$223.68M
Change (1 day)
1.21%
Change (1 year)
0.00%
Country
CA
Trade Neovasc Inc. (NVCN)

Category

Operating Margin for Neovasc Inc. (NVCN)
Operating Margin as of 2026 TTM: 0.00%
According to Neovasc Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Neovasc Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
28.09% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.